TL;DR: Sequence Bio is a Y Combinator Summer 2019 startup Discovering the true signals of disease to power life-changing drugs., currently active with a team of 52.
Discovering the true signals of disease to power life-changing drugs.
Last verified:
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
Built by LemStudio
Yes. Sequence Bio was funded by Y Combinator in the Summer 2019 batch. Discovering the true signals of disease to power life-changing drugs.
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
Sequence Bio was part of Y Combinator's Summer 2019 batch.
Sequence Bio has a team of 52 people according to Y Combinator's directory.
Sequence Bio is currently listed as Active with a team of 52 in Y Combinator's directory.
Loading interactive view…